表紙SALE
市場調查報告書

醫藥品開發、臨床試驗AI - 全球市場:2020年

AI in Drug Development & Clinical Trials - World - 2020

出版商 Signify Research 商品編碼 949933
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
醫藥品開發、臨床試驗AI - 全球市場:2020年 AI in Drug Development & Clinical Trials - World - 2020
出版日期: 將在2020年10月30日內容資訊: 英文
簡介

本報告提供以下的內容。

報告概要

市場

  • 產品和最終市場
  • 推動市場要素與成長的障礙
  • 市場規模與成長預測

技術

  • AI應用的市場分析
  • 先進的機器學習和深度學習的影響
  • 下一代DNA定序、處理技術的影響

競爭

  • 主要供應商的市場佔有率估計
  • 主要供應商的詳細介紹,SWOT分析
  • 潛在的合作夥伴與收購目標

目錄

2019年∼2024年的市場指標

市場明細:各主要地區、國家

  • 南北美洲
    • 美國
    • 加拿大
    • 巴西
    • 墨西哥
    • 其他南美
  • 歐洲、中東、非洲
    • 荷比盧三國
    • 法國
    • DACH
    • 義大利
    • 北歐
    • 英國/愛爾蘭
    • 西班牙/葡萄牙
    • 東歐
    • 中東
    • 非洲
  • 亞洲
    • 大洋洲
    • 印度
    • 韓國

各國的市場明細:各系列產品

  • 產品類型
    • 資訊、疾病模式
    • 醫藥品設計、最佳化
    • 前臨床、臨床試驗
  • 產品零組件
    • 軟體
    • 硬體設備
    • 服務
  • 授權模式
    • 永久許可證
    • 訂閱許可證
    • 各研究的費用
    • 夥伴關係

各產品的明細:各臨床應用

  • 腫瘤
  • 神經
  • 感染疾病
  • 其他/整體

各產品的明細:各架構

  • 內部部署(含私有雲端)
  • 雲端(託管)
目錄

Report Overview

Market

  • Identify the products and end-markets driving growth
  • Review the market drivers and barriers for growth
  • Quantitative analysis of market size and forecast growth

Technology

  • Market analysis for AI applications in information and disease models, drug design & optimisation, preclinical & clinical trials
  • Impact of advanced machine learning and deep learning
  • Influence of next generation DNA sequencing and processing technologies

Competition

  • Market share estimates for the leading vendors
  • Detailed profiles of selected vendors, with SWOT analysis for each
  • Identify potential partners and acquisition targets

Strategy

  • Review go-to-market strategies
  • Analysis and insights to support your strategy and business planning
  • Product pricing and software delivery strategies

Report Features:

  • Expert commentary on the market Trends
  • Primary research method ensures accuracy and reliability
  • Direct access to the lead Analyst
  • Highly data-centric, with numerous segmentations of the market
  • Detailed analysis by product, sales model and application to highlight growth opportunities
  • Robust forecasts driven by proprietary database of hospital infrastructure
  • Report focused on global market coverage with detailed country analysis
  • Actionable, jargon-free analyst insight and opinion

Key issues Addressed:

  • How large is the global market for AI in drug development in terms of revenue and how will this change over the next five years?
  • How does the market break out in terms of applications for information synthesis, drug design and clinical trials?
  • How does the market break out in terms of clinical areas (oncology, neurology, infectious disease, other)?
  • How is the market split between licencing models?
  • What are the main drivers behind each market segment?
  • Who are the leading vendors and what is needed to stay competitive?

Table of Contents

This is the preliminary research scope. The below outlines market splits that are being considered for inclusion in the scope.

Market metrics presented for the period 2019 to 2024.

The report is primarily organised by Product Group, with dedicated chapters for the following:

  • Information & Disease Models (AI based applications to: aggregate and synthesize information, understand mechanisms of disease, establish biomarkers, generate data and models)
  • Drug Design & Optimisation (AI applications to: repurpose existing drugs, generate novel drug candidates, validate and optimise drug candidates, design drugs)
  • Preclinical & Clinical Trials (AI applications to: design preclinical experiments, run preclinical experiments, design clinical trials, recruit for clinical trials, optimise clinical trials, publish data, analyse real world evidence)

The market will be broken down by Geographic Region into the following major regions and countries/subregions:

  • Americas
    • US
    • Canada
    • Brazil
    • Mexico
    • Rest of Latin America
  • EMEA
    • Benelux
    • France
    • DACH
    • Italy
    • Nordics
    • UK/Eire
    • Spain/Portugal
    • E. Europe
    • Middle East
    • Africa
  • Asia
    • Oceania
    • India
    • South Korea

For each country the market is segmented by Product Group into:

  • Product Type
    • Information & Disease Models
    • Drug Design & Optimisation
    • Preclinical & Clinical Trials
  • Product Component
    • Software
    • Hardware
    • Service
  • Licensing Model
    • Perpetual License
    • Subscription License
    • Fee per Study
    • Partnership

Each product is then further segmented by Clinical Application into:

  • Oncology
  • Neurology
  • Infectious Disease
  • Other/General

Each product is then further segmented by Architecture into:

  • On-Premise (inc. private cloud)
  • Cloud (hosted)